Chemical Formula: C38H75NO8

Chemical Formula C38H75NO8

Found 62 metabolite its formula value is C38H75NO8

C14DH GlcCer

N-(tetradecanoyl)-1-beta-glucosyl-sphinganine

C38H75NO8 (673.5492390000001)


   

alpha-D-galactosyl-N-tetradecanoylsphinganine

alpha-D-galactosyl-N-tetradecanoylsphinganine

C38H75NO8 (673.5492390000001)


A glycodihydroceramide having alpha-D-galactosyl component and the ceramide N-acyl group specified as tetradecanoyl.

   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

N-(dodecanoyl)-1-beta-glucosyl-eicosasphinganine

N-(dodecanoyl)-1-beta-glucosyl-eicosasphinganine

C38H75NO8 (673.5492390000001)


   

N-(pentadecanoyl)-1-beta-glucosyl-heptadecasphinganine

N-(pentadecanoyl)-1-beta-glucosyl-heptadecasphinganine

C38H75NO8 (673.5492390000001)


   

N-(decanoyl)-1-beta-glucosyl-docosasphinganine

N-(decanoyl)-1-beta-glucosyl-docosasphinganine

C38H75NO8 (673.5492390000001)


   

N-(tridecanoyl)-1-beta-glucosyl-nonadecasphinganine

N-(tridecanoyl)-1-beta-glucosyl-nonadecasphinganine

C38H75NO8 (673.5492390000001)


   

N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradecan-2-yl]octadecanamide

N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradecan-2-yl]octadecanamide

C38H75NO8 (673.5492390000001)


   

N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentadecan-2-yl]heptadecanamide

N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentadecan-2-yl]heptadecanamide

C38H75NO8 (673.5492390000001)


   

N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadecan-2-yl]hexadecanamide

N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadecan-2-yl]hexadecanamide

C38H75NO8 (673.5492390000001)


   

Hex1Cer(32:0)

Hex1Cer(d16:0_16:0)

C38H75NO8 (673.5492390000001)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved